www.fdanews.com/articles/96400-vivalis-cell-lines-show-mab-production-power
Vivalis Cell Lines Show MAb Production Power
July 27, 2007
French firm Vivalis has announced the first data evaluating its proprietary EBx cell lines for the production of monoclonal antibodies (MAbs), with initial results suggesting high cytotoxic properties in the resultant MAbs.
DrugResearcher.com